Skip to main content
. 2011 May 12;96(9):1366–1370. doi: 10.3324/haematol.2011.042598

Figure 1.

Figure 1.

Kaplan-Meier curves showing the impact of empirical (dotted line) versus pre-emptive (solid line) therapy on 90-day mortality in all 397 patients (A), and in the subgroup of 321 patients with AML at first line of treatment (B). P=0.002 for both A and B.